Literature DB >> 25571029

A novel approach to malignant-benign classification of pulmonary nodules by using ensemble learning classifiers.

A Tartar, A Akan, N Kilic.   

Abstract

Computer-aided detection systems can help radiologists to detect pulmonary nodules at an early stage. In this paper, a novel Computer-Aided Diagnosis system (CAD) is proposed for the classification of pulmonary nodules as malignant and benign. The proposed CAD system using ensemble learning classifiers, provides an important support to radiologists at the diagnosis process of the disease, achieves high classification performance. The proposed approach with bagging classifier results in 94.7 %, 90.0 % and 77.8 % classification sensitivities for benign, malignant and undetermined classes (89.5 % accuracy), respectively.

Mesh:

Year:  2014        PMID: 25571029     DOI: 10.1109/EMBC.2014.6944661

Source DB:  PubMed          Journal:  Conf Proc IEEE Eng Med Biol Soc        ISSN: 1557-170X


  5 in total

1.  Lung Nodule Detection in CT Images Using a Raw Patch-Based Convolutional Neural Network.

Authors:  Qin Wang; Fengyi Shen; Linyao Shen; Jia Huang; Weiguang Sheng
Journal:  J Digit Imaging       Date:  2019-12       Impact factor: 4.056

2.  Ensemble classification for predicting the malignancy level of pulmonary nodules on chest computed tomography images.

Authors:  Ning Xiao; Yan Qiang; Muhammad Bilal Zia; Sanhu Wang; Jianhong Lian
Journal:  Oncol Lett       Date:  2020-04-27       Impact factor: 2.967

3.  Automatic Estimation of Osteoporotic Fracture Cases by Using Ensemble Learning Approaches.

Authors:  Niyazi Kilic; Erkan Hosgormez
Journal:  J Med Syst       Date:  2015-12-12       Impact factor: 4.460

4.  3D multi-view convolutional neural networks for lung nodule classification.

Authors:  Guixia Kang; Kui Liu; Beibei Hou; Ningbo Zhang
Journal:  PLoS One       Date:  2017-11-16       Impact factor: 3.240

Review 5.  Application of Artificial Intelligence in Discovery and Development of Anticancer and Antidiabetic Therapeutic Agents.

Authors:  Amal Alqahtani
Journal:  Evid Based Complement Alternat Med       Date:  2022-04-25       Impact factor: 2.650

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.